Protecting Access to Pain Relief Coalition

Spending by Year

Lobbying Firms

What They Lobby For

• Advocating for policy to ensure patient access to pain relief; H.R. 664, Stop OD Act of 2017; S.1554, Safer Prescribing of Controlled Substances Act; H.R. 3964, Opioid Addiction Prevention Act of 2017; H.R. 2063, Opioid PACE Act of 2017.
• Advocating for policy to ensure patient access to pain relief; S.2680, Opioid Crisis Response Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act.
• Advocating for policy to ensure patient access to pain relief; S.2680, Opioid Crisis Response Act of 2018; H.R. 6, SUPPORT for Patients and Communities Act; HHS Pain Management Interagency Task Force.
• HHS Pain Management Interagency Task Force; FDA/USDA appropriations bill; Regulation of over-the-counter pain medicine.
• H.R. 1865, Further Consolidated Appropriations Act, 2020, FDA/USDA appropriations; Regulation of over-the-counter pain medicine.
• FY 2021 appropriations for the US Food and Drug Administration; The Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 (S. 2740), which was included in Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748).
• FY 2021 appropriations for the US Food and Drug Administration; H.R. 5172, NOPAIN Act.
• Coronavirus Response and Relief Supplemental Appropriations Act, 2021 (H.R. 133).
• Labor HHS Appropriations legislation; draft legislation regarding pain management.
• Labor HHS Appropriations.

Related Investigations

Explore More